Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients

LivaNova616 enrolled

Overview

Observational study is evaluating Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) thérapies as a function of ventricular pacing

This protocol consists in a non-interventional multi-centre, prospective study. The observational study will also answer the question of the impact of ventricular pacing on the outcome of patients implanted with ICD \& CRT-D devices and how the ICD \& CRT-D devices are used in clinical practice through two years follow-up.

Study Type

OBSERVATIONAL

Enrollment

616

Conditions

Ventricular Tachycardia Ventricular Fibrillation

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Main inclusion Criteria: •Patient implanted (primo implantation or replacement) with an ICD (OVATIO VR 6250, DR 6550, CRT 6750 models, or any similar or higher range device, that includes specific diagnostic and therapeutic functionalities, mandatory to make homogeneous the collection of data) Main exclusion Criteria: * Presence of a contra-indication to the ICD therapy. * Life expectancy less than 12 months.

Locations (1)

CCN

Saint-Denis, France

Outcomes

Primary Outcomes

VT/VF episodes according to ventricular pacing (> and <50%)

Device-based data

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.